Suboxone
Suboxone is composed of buprenorphine and naloxone, which can help manage withdrawal symptoms by minimizing the withdrawal or cravings for opioids. It can also offer some relief by binding to opioid receptors to provide relief without producing any sort of “high” or “euphoria” feeling. Vivitrol on the other hand is an injection containing naltrexone, this stops heroin or any opioid from creating any kind of “high” feelings. The vivitrol injection also significantly reduces cravings.
For those suffering from addiction to opioids, the path to treatment and healing can seem daunting, or even impossible. At Lawrence Medical Center, we serve people in all walks of life, and we believe that anyone can achieve genuine healing. We treat all our patients with the respect and equality they deserve.
Suboxone® is a medicine that can be taken regularly to relieve the symptoms of opioid withdrawal. Suboxone® treatment is part of a comprehensive management program that helps patients suffering from addiction. Our providers provide safe and effective treatment at our locations in Lawrence and Peabody, Massachusetts
Buprenorphine, an FDA-approved medication for addiction treatment and pain relief, cuts opioid overdose death rates in half. Yet nearly 80% of Americans with opioid use disorder (OUD) do not receive buprenorphine or other medication-assisted treatment (MAT).
- Buprenorphine compared to methadone and naltrexone
- Accessibility obstacles
- How to start a patient on buprenorphine
- Where can a patient start buprenorphine?
- Maintenance dosage
- Treatment duration: detox, maintenance, tapering
- Monitoring and diversion
- Substance use
- Behavioral health treatments
- Advantages of using buprenorphine for chronic pain
- Elderly patients with chronic pain
- Treating pain in the emergency department and hospital
- Hospitalized and perioperative patients on buprenorphine
- Laws regulating buprenorphine prescribing
- Getting prescriptions approved by health plans
- Documentation required by federal and/or Massachusetts laws
Sublocade
Sublocade is a medication utilized for opioid use disorder treatment, containing the active ingredient buprenorphine administered monthly via injection. It provides a sustained-release formulation of buprenorphine, ensuring a long-lasting therapeutic impact.
- Relapse Prevention: Sublocade helps prevent relapse by reducing cravings and withdrawal symptoms associated with opioid addiction. Its extended-release formulation provides a consistent level of medication in the body, minimizing the risk of relapse.
- Increased Compliance: With Sublocade, medication adherence is improved as there is no need for daily dosing or the potential for diversion. Once the monthly injection is administered, individuals do not have to worry about taking medication on a daily basis, reducing the risk of missed doses.
- Decreased Stigma: Sublocade can help reduce the stigma often associated with medication-assisted treatment (MAT) for opioid addiction. As a long-acting injectable medication, it offers a discreet treatment option, allowing individuals to focus on their recovery without the potential judgment or stigma associated with daily medication administration.
- Individualized Treatment: Sublocade is tailored to meet the specific needs of each patient. Dosage adjustments can be made based on individual response and medical supervision, ensuring an individualized treatment plan that addresses each person’s unique circumstances.
- Comprehensive Care: Sublocade is most effective when used as part of a comprehensive treatment program that includes counseling, therapy, and other support services. Combining medication with behavioral interventions provides a holistic approach to addiction treatment, addressing the physical, psychological, and social aspects of recovery.
It’s important to note that Sublocade should only be administered under the supervision of a qualified healthcare professional experienced in the treatment of opioid addiction. They will evaluate the individual’s medical history, assess their suitability for Sublocade, and provide appropriate guidance and support throughout the treatment process.
Vivitrol
VIVITROL should be part of a comprehensive management program that includes psycho-social support.
- Treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL. Patients should not be actively drinking at the time of initial VIVITROL administration.
- Prevention of relapse to opioid dependence, following opioid detoxification.
- VIVITROL should be part of a comprehensive management program that includes psycho-social support.
Lawrence Medical Center Is An Innovative Primary Care Provider As Well As A Dually Licensed* Integrated Specialty Medical Practice That Conveniently Offers All Your Medical And Recovery Support Service Needs In One Location
Copyright © 2025 Lawrence Medical Centr. All rights reserved.